Mirae Asset Global ETFs Holdings’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138K Buy
+56,510
New +$129K ﹤0.01% 2662
2025
Q2
– Sell
-27,447
Closed -$13.1K – 3120
2025
Q1
$13.1K Buy
27,447
+1,170
+4% +$879 ﹤0.01% 3012
2024
Q4
$26.5K Buy
26,277
+1,140
+5% +$1.55K ﹤0.01% 2980
2024
Q3
$43K Buy
25,137
+13,748
+121% +$26.9K ﹤0.01% 2948
2024
Q2
$29K Buy
+11,389
New +$36K ﹤0.01% 2874

Other funds holding IPSC

Mirae Asset Global ETFs Holdings's IPSC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Century Therapeutics (IPSC) in Q2 2026: 56,510 shares worth $138K. The stake represents ﹤0.01% of the portfolio and ranks #2662 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in IPSC as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in IPSC in Q2 2024 and has held it in 5 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 56,510 shares of Century Therapeutics worth $138K as of Q2 2026.
  • Century Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2662 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Century Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.